News

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System
Boston Scientific Corporation (NYSE: BSX) has received U.S. Food and Drug Administration (FDA) approval to expand the ...
FoodNavigator-USA4d
11 major moves in the synthetic food dye fight
Discover why synthetic food dyes are being phased out in the US, how major brands are responding, and what challenges the ...
CURE10d
FDA Approves CAR T Therapy Label Updates Across Various Blood Cancers
Label updates have been approved by the FDA for the CAR T-cell therapies Breyanzi and Abecma in large B cell lymphoma and ...
MPR7d
FDA Removes REMS, Reduces Monitoring Requirements For Breyanzi and Abecma
The Breyanzi REMS program and the Abecma REMS program were established due to the risk of cytokine release syndrome and neurologic toxicities.
KSL6d
FDA to revise ADHD stimulants labels to warn of weight loss risk in children under 6
The Food and Drug Administration is revising the labeling of all extended-release stimulants used to treat attention-deficit hyperactivity disorder to include warnings about the risk of weight loss ...